Trial site
Cleveland Clinic, Case Comprehensive Cancer Center
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer3 trials
- Acute myeloid leukaemia1 trial
- Brain metastases1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Sarcoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Early phase 12 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Withdrawn2 trials
- Lead sponsor
- Case Comprehensive Cancer Center9 trials
- George T. Budd1 trial
Running trials
Active, not recruiting
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Recruiting
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Active, not recruiting
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer
Active, not recruiting
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
Active, not recruiting
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Recruiting
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Brain metastases1 recruiting
- Sarcoma1 recruiting
Closed trials
Withdrawn
Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms
Withdrawn
Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
Completed
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer
Completed
Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans
Site data: ClinicalTrials.govUpdated 15 Nov 2026